Plunkett Research Online: Evotec SE

EVOTEC SE (EVO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inf.....



Evotec SE
Ticker: EVO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 49 40560810
Fax: 650 266-1505
Address: Essener Bogen 7
Manfred Eigen Campus
Hamburg, 22419 Germany

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Drug Discovery
Drug Development
Technologies
Contacts Description
Werner Lanthaler CEO/Other Corporate Officer
Enno Spillner CFO/Other Corporate Officer
See More

Auditor: BDO AG Wirtschaftsprufungsgesellschaft
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (EUR) Bonus (EUR)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: